#USA #New York #Class Action #Pomerantz LLP #Tempus AI

Investor Alert: Class Action Lawsuit Against Tempus AI, Inc.

Pomerantz Law Firm has initiated a class action lawsuit against Tempus AI, Inc., sending a strong message to investors who have suffered financial losses. Investors are encouraged to reach out, especially those who purchased securities in Tempus during the class period.

Background Information

On June 27, 2025, it was unveiled that Pomerantz LLP had filed the lawsuit, which specifically targets potential securities fraud and claims regarding unlawful business practices within Tempus AI. This legal action arises from various allegations that have surfaced about the company's internal operations and financial reporting. Advancing forward, the firm encourages any affected investors to connect with Danielle Peyton, a contact person at Pomerantz, to discuss their circumstances and explore their options. Communication can be conducted via email or phone, but it is vital that investors provide key details about themselves, including contact information and the number of shares acquired.

Key Deadline for Investors

Investors have a limited time frame; they must request to be appointed as Lead Plaintiff by August 12, 2025. This is a crucial step for those looking to partake actively in the pending litigation. A copy of the lawsuit is available on the Pomerantz Law Firm's website for those seeking further information on this legal proceeding.

Allegations Against Tempus AI

The class action lawsuit primarily stems from a report released by Spruce Point Capital Management on May 28, 2025. The report raised serious concerns regarding Tempus AI's business practices. Notable allegations in the report highlighted that the company appeared to be engaging in aggressive accounting methods and financial reporting. Additionally, it pointed out that certain board members and executives had past associations with companies that faced significant financial difficulties and were forced to restate their fiscal results.

Moreover, particular attention was placed on the strategic partnerships that Tempus formed with other organizations such as AstraZeneca and Pathos AI, which raised eyebrows and warranted further scrutiny as claimed by the report.

Following the report's publication, there was a significant dip in Tempus AI’s stock price during trading hours on that very day, indicating the immediate impact of these revelations on investor confidence.

About Pomerantz LLP

Pomerantz LLP is a renowned name in the realm of corporate law, particularly recognized for its expertise in handling class action lawsuits related to securities and antitrust issues. Established over 85 years ago by Abraham L. Pomerantz, the firm holds a legacy of advocating for victims of corporate misconduct and securities fraud. They have secured substantial victories for clients in the past, showcasing a consistent record of fighting for justice amidst corporate wrongdoing.

With offices in major cities including New York, Chicago, and Los Angeles, as well as international locations in London, Paris, and Tel Aviv, their reach and influence in litigation are significant.

Conclusion

Investors are urged to take note of this situation and act promptly if they believe they may have been adversely affected by their investments in Tempus AI. The legal window for joining this class action is closing soon, making it essential for investors to stay informed and engaged. Pomerantz LLP is ready to assist in providing the necessary resources and legal representation as this case unfolds. Interested parties should not hesitate to reach out to the firm to ensure their rights are pursued effectively in this pressing matter.